EIDX - Eidos Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - EIDX (1731831)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
57 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-09-17
EIDXFox Jonathan CSee RemarksS - Sale$50.16-5,767380,967-1%-$289,259
M
2020-09-14
EIDXFox Jonathan CSee RemarksS - Sale$50.14-4,233386,734-1%-$212,224
D
2020-09-10
EIDXTurtle CameronChief Business OfficerS - Sale+OE$47.00-2,50070,531-3%-$117,500
D
2020-08-03
EIDXTurtle CameronChief Business OfficerS - Sale+OE$39.95-10,00070,531-12%-$399,450
2020-07-07
EIDXFox Jonathan CSee RemarksS - Sale$50.00-5,000390,967-1%-$250,000
2020-06-03
EIDXFox Jonathan CSee RemarksS - Sale$50.00-5,000394,879-1%-$250,000
2020-05-28
EIDXFox Jonathan CSee RemarksS - Sale$50.00-5,000401,475-1%-$250,000
D
2020-05-26
EIDXTurtle CameronChief Business OfficerS - Sale+OE$47.00-2,50075,155-3%-$117,500
D
2020-05-01
EIDXTurtle CameronChief Business OfficerS - Sale+OE$40.84-10,00075,155-12%-$408,433
M
2020-04-23
EIDXFox Jonathan CSee RemarksS - Sale$50.00-5,000406,475-1%-$250,000
D
2020-04-20
EIDXValle FrancoSVP, FinanceS - Sale+OE$49.79-2,0000-100%-$99,580
D
2020-03-26
EIDXValle FrancoSVP, FinanceS - Sale+OE$48.26-5,0000-100%-$241,310
D
2020-03-02
EIDXValle FrancoSVP, FinanceS - Sale+OE$52.33-3,0000-100%-$156,980
2020-03-02
EIDXFox Jonathan CSee RemarksS - Sale$51.57-10,000411,475-2%-$515,706
2020-02-13
EIDXFox Jonathan CSee RemarksS - Sale$54.00-10,000421,475-2%-$540,000
D
2020-02-03
EIDXTurtle CameronChief Business OfficerS - Sale+OE$53.65-12,50080,155-13%-$670,640
M
2020-01-14
EIDXFox Jonathan CSee RemarksS - Sale$55.01-10,000433,107-2%-$550,072
2019-12-18
EIDXSinha UmaChief Scientific OfficerS - Sale$61.90-12,500331,081-4%-$773,794
D
2019-12-09
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$59.66-10,00036,470-22%-$596,570
D
2019-12-06
EIDXTurtle CameronChief Business OfficerS - Sale+OE$59.25-10,00085,155-11%-$592,452
2019-12-04
EIDXFox Jonathan CSee RemarksS - Sale$58.90-10,000443,377-2%-$589,048
DM
2019-12-03
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$58.93-20,00036,470-35%-$1,178,551
2019-11-25
EIDXFox Jonathan CSee RemarksS - Sale$56.52-10,000454,377-2%-$565,218
2019-11-21
EIDXFox Jonathan CSee RemarksS - Sale$55.11-10,000464,377-2%-$551,073
2019-11-20
EIDXTurtle CameronChief Business OfficerS - Sale$55.75-10,00085,155-11%-$557,502
DM
2019-11-21
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$55.02-35,00036,470-49%-$1,925,533
M
2019-11-15
EIDXFox Jonathan CSee RemarksS - Sale$48.65-15,000474,377-3%-$729,703
2019-10-15
EIDXFox Jonathan CSee RemarksS - Sale$36.16-5,000489,377-1%-$180,818
2019-09-25
EIDXSinha UmaChief Scientific OfficerS - Sale$38.41-2,500343,581-1%-$96,016
2019-09-16
EIDXFox Jonathan CSee RemarksS - Sale$45.74-5,000494,377-1%-$228,722
2019-09-04
EIDXTurtle CameronChief Business OfficerS - Sale$41.58-5,00095,155-5%-$207,923
2019-08-15
EIDXFox Jonathan CSee RemarksS - Sale$38.72-5,000499,377-1%-$193,596
2019-07-25
EIDXSinha UmaChief Scientific OfficerS - Sale$36.13-5,000346,081-1%-$180,627
2019-07-15
EIDXFox Jonathan CSee RemarksS - Sale$40.04-15,000504,377-3%-$600,561
D
2019-07-10
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$39.37-5,00036,470-12%-$196,850
2019-07-03
EIDXSatvat Ali J.Dir, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXKumar NeilCEO, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXAguiar EricDir, 10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-07-03
EIDXBridgebio Pharma, Inc.10%P - Purchase$29.90+882,35324,575,501+4%+$26,382,796
2019-06-05
EIDXSiu ChristineCFO, SecretaryS - Sale$29.97-17,00019,470-47%-$509,487
2019-06-04
EIDXTurtle CameronChief Business OfficerS - Sale$31.64-10,000100,155-9%-$316,402
2019-05-30
EIDXFox Jonathan CSee RemarksS - Sale$32.64-5,000516,527-1%-$163,179
2019-05-24
EIDXSatvat Ali J.Dir, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXKumar NeilCEO, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXAguiar EricDir, 10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-24
EIDXBridgebio Pharma, Inc.10%P - Purchase$25.93+1,103,84823,693,148+5%+$28,622,779
2019-05-23
EIDXSinha UmaChief Scientific OfficerS - Sale$27.28-5,000349,312-1%-$136,376
2019-05-03
EIDXFox Jonathan CSee RemarksS - Sale$25.03-5,000521,527-1%-$125,150
2019-05-01
EIDXFox Jonathan CSee RemarksS - Sale$25.46-5,000527,608-1%-$127,287
D
2019-04-24
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$26.11-5,00034,701-13%-$130,550
2019-04-15
EIDXFox Jonathan CSee RemarksS - Sale$23.11-5,000531,527-1%-$115,550
D
2019-03-19
EIDXSiu ChristineCFO, SecretaryS - Sale+OE$19.66-11,91334,701-26%-$234,210
A
2018-12-10
EIDXBridgebio Pharma LLC10%P - Purchase$13.33+40,65322,589,3000%+$542,063
AM
2018-12-06
EIDXBridgebio Pharma LLC10%P - Purchase$13.67+80,14422,548,6470%+$1,095,867
2018-12-10
EIDXBridgebio Pharma LLC10%S - Sale$13.33-40,65322,589,3000%-$542,063
M
2018-12-06
EIDXBridgebio Pharma LLC10%S - Sale$13.67-80,14422,548,6470%-$1,095,867
M
2018-12-03
EIDXBridgebio Pharma LLC10%P - Purchase$14.92+2,853,84822,468,503+15%+$42,589,910
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top